References
- European Medicines AgencyGuideline on the investigation of bioequivalence2010 Available from: http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdfAccessed July 24, 2012
- Del TaccaMPasqualettiGDi PaoloALack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteersBr J Clin Pharmacol200968344219660001
- CrawfordPFeelyMGubermanAKramerGAre there potential problems with generic substitution of antiepileptic drugs? A review of issuesSeizure20061516517616504545
- BergMJGrossRATomaszewskiKJZingaroWMHaskinsLSGeneric substitution in the treatment of epilepsy: case evidence of breakthrough seizuresNeurology20087152553018695164
- LeLorierJDuhMSParadisPEClinical consequences of generic substitution of lamotrigine for patients with epilepsyNeurology2008702179218618505997
- MastorakiEMichalopoulosAKriarasIIncidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroximeJ Infect200856353917983660
- HalkinHShapiroJKurnikDLoebsteinRShalevVKokiaEIncreased warfarin doses and decreased international normalized ratio response after nationwide generic switchingClin Pharmacol Ther20037421522112966365
- ElkoshiZBehrDMirimskyATsvetkovIDanonAMultiple-dose studies can be a more sensitive assessment for bioequivalence than single-dose studies: the case with omeprazoleClin Drug Invest200222585592
- ShimataniTInoueMKuroiwaTXuJMienoHTazumaSAcid-suppressive effects of generic omeprazole: comparison of three brands of generic omeprazole with original omeprazoleDig Liver Dis20063855455916524789
- ReiffelJAIssues in the use of generic antiarrhythmic drugsCurr Opin Cardiol200116232911124715
- ChenuFBattenLAZernigGLadstaetterEHébertCBlierPComparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover studyJ Clin Psychiatry20097095896619653973
- MeredithPAPotential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt formsCurr Med Res Opin2009252179218919601710
- ChassaingCSchmidtJEschalierACardotJMDubrayCHyperalgesia induced by cutaneous freeze injury for testing analgesics in healthy volunteersBr J Clin Pharmacol2006438939716542199
- MeinekeITürckDPopulation pharmacokinetic analysis of meloxicam in rheumatoid arthritis patientsBr J Clin Pharmacol200355323812534638
- SteningKErikssonOWahrenLBergGHammarMBlomqvistAPain sensations to the cold pressor test in normally menstruating women: comparison with men and relation to menstrual phase and serum sex steroid levelsAm J Physiol Regul Integr Comp Physiol2007293R1711R171617652363
- RingCVeldhuijzen van ZantenJJKavussanuMEffects of sex, phase of the menstrual cycle and gonadal hormones on pain in healthy humansBiol Psychol20098118919119393713
- KowalczykWJSullivanMAEvansSMBisagaAMVosburgSKComerSDSex differences and hormonal influences on response to mechanical pressure pain in humansJ Pain20101133034219853526
- TeepkerMPetersMVedderHSchepelmannKLautenbacherSMenstrual variation in experimental pain: correlation with gonadal hormonesNeuropsychobiology20106113114020110738
- GschwendMHErenmemişoğluAMartinWTamurUKanzikIHincalAAPharmacokinetic and bioequivalence study of meloxicam tablets in healthy male subjectsArzneimittelforschung20075726426817598697
- TangsucharitPKampanJKanjanawartSBioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteersInt J Clin Pharmacol Ther20094763864219825327
- HasanSMShoaibMHHassanFRehmanIUBioequivalence studies of two brands of meloxicam tablets in healthy Pakistani volunteersPak J Pharm Sci20092219920419339233
- AhmadMMurtazaGAkhtarNBioequivalence study of two brands of meloxicam tablets in healthy human Pakistani male subjectsActa Pol Pharm20116811511921485709
- PasqualettiGGoriGBlandizziCDel TaccaMHealthy volunteers and early phases of clinical experimentationEur J Clin Pharmacol20106664765320461363
- European Medicines AgencyGuideline for good clinical practice2002 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdfAccessed July 24, 2012
- World Medical Association Declaration of Helsinki 2008Ethical principles for medical research involving human subjects2008 Available from: http://www.wma.net/en/30publications/10policies/b3/17c.pdfAccessed July 24, 2012
- BaeJWKimMJJangCGLeeSYDetermination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic studyJ Chromatogr B Analyt Technol Biomed Life Sci20078596973
- PolilloMTasciniCLastellaMA rapid high-performance liquid chromatography method to measure linezolid and daptomycin concentrations in human plasmaTher Drug Monit20103220020520216115
- MeyerRACampbellJNRajaSNPeripheral neural mechanisms of nociceptionWallPDMelzackRBonicaJJTextbook of PainNew YorkChurchill Livingstone19951344
- SchuirmannDJA comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailabilityJ Pharmacokinet Biopharm1987156576803450848
- ChenMLShahVPatnaikRBioavailability and bioequivalence: an FDA regulatory overviewPharm Res2001181645165011785681
- YuLXAmidonGLPolliJEBiopharmaceutics classification system: the scientific basis for biowaiver extensionsPharm Res20021992192512180542
- World Health OrganizationProposal to waive in vivo bioequivalence requirements for the WHO model list of essential medicines: immediate release, solid oral dosage forms2005 Available from: http://www.who.int/medicines/services/expertcommittees/pharmprep/QAS04_109Rev1_Waive_invivo_bioequiv.pdfAccessed July 24, 2012
- MeredithPBioequivalence and other unresolved issues in generic drug substitutionClin Ther2003252875289014693311
- TürckDRothWBuschUA review of the clinical pharmacokinetics of meloxicamBr J Rheumatol199635Suppl 113168630630
- Marcelín-JiménezGHernándezJAAngelesAPBioequivalence evaluation of two brands of meloxicam tablets (Promotion and Mobicox): pharmacokinetics in a healthy female Mexican populationBiopharm Drug Dispos20052616717115841494
- DaviesNMSkjodtNMClinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drugClin Pharmacokinet19993611512610092958
- PerryRPerspectives on the bioequivalence and therapeutic equivalence of generic formulations: an overview of the landscapeClin Ther2010321796179721194603
- AlvarezCAMascarenasCTimmermanIIncreasing psychosis in a patient switched from Clozaril to generic clozapineAm J Psychiatry2006163474616585457